NATIONAL INSTITUTES OF HEALTH
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary, Private
- Established
- 1948-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.nidcr.nih.gov
Total Body Irradiation for Bone Marrow Transplants: Collaborative Efforts
Phase 2
Completed
- Conditions
- Neoplasm
- First Posted Date
- 2001-11-15
- Last Posted Date
- 2008-03-04
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 100
- Registration Number
- NCT00026858
- Locations
- 🇺🇸
National Cancer Institute (NCI), Bethesda, Maryland, United States
Research in Skin Inflammation
Completed
- Conditions
- Psoriasis
- First Posted Date
- 2001-11-15
- Last Posted Date
- 2008-03-04
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 10
- Registration Number
- NCT00026741
- Locations
- 🇺🇸
National Cancer Institute (NCI), Bethesda, Maryland, United States
Correlation of HIV Levels With Clinical and Immunologic Outcome in Children Treated With Didanosine
Completed
- Conditions
- HIV Infection
- First Posted Date
- 2001-11-15
- Last Posted Date
- 2008-03-04
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 82
- Registration Number
- NCT00026676
- Locations
- 🇺🇸
National Cancer Institute (NCI), Bethesda, Maryland, United States
Effects of Raloxifene on Hormone Levels
Phase 2
Completed
- Conditions
- Breast Cancer
- First Posted Date
- 2001-11-15
- Last Posted Date
- 2008-03-04
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 60
- Registration Number
- NCT00026962
- Locations
- 🇺🇸
National Cancer Institute (NCI), Bethesda, Maryland, United States
A Phase II Evaluation of Telesurgery Systems
Phase 2
Completed
- Conditions
- Laparoscopy
- First Posted Date
- 2001-11-15
- Last Posted Date
- 2008-03-04
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 30
- Registration Number
- NCT00026923
- Locations
- 🇺🇸
National Cancer Institute (NCI), Bethesda, Maryland, United States
Study of Etoposide in Breast Cancer Patients
Completed
- Conditions
- Breast Cancer
- First Posted Date
- 2001-11-15
- Last Posted Date
- 2008-03-04
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 33
- Registration Number
- NCT00026949
- Locations
- 🇺🇸
National Cancer Institute (NCI), Bethesda, Maryland, United States
A Pilot Study to Investigate the Clinical Utility of the Peregrine Monte Carlo Dose Calculation System for Radiation Therapy Treatment Planning
Phase 2
Completed
- Conditions
- Neoplasm
- First Posted Date
- 2001-11-15
- Last Posted Date
- 2008-03-04
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 140
- Registration Number
- NCT00026936
- Locations
- 🇺🇸
National Cancer Institute (NCI), Bethesda, Maryland, United States
Analysis of Molecular Markers of Drug Resistance in Tumor Biopsies From Previously Untreated Aggressive Non-Hodgkin's Lymphoma
Completed
- Conditions
- Non-Hodgkin Lymphoma
- First Posted Date
- 2001-11-15
- Last Posted Date
- 2008-03-04
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 200
- Registration Number
- NCT00026910
- Locations
- 🇺🇸
National Cancer Institute (NCI), Bethesda, Maryland, United States
Long-Term Survival With HIV: Psychological and Behavioral Factors Associated With the Transition From Adolescence to Young Adulthood
Completed
- Conditions
- HIV Infection
- First Posted Date
- 2001-11-15
- Last Posted Date
- 2008-03-04
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 55
- Registration Number
- NCT00026806
- Locations
- 🇺🇸
National Cancer Institute (NCI), Bethesda, Maryland, United States
Evaluation of New Test Method to Measure Kidney Function
Completed
- Conditions
- Kidney Disease
- First Posted Date
- 2001-11-15
- Last Posted Date
- 2008-03-04
- Target Recruit Count
- 150
- Registration Number
- NCT00026715
- Locations
- 🇺🇸
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda, Maryland, United States
© Copyright 2025. All Rights Reserved by MedPath